We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Additional Imaging Prior to Cancer Surgery May Not Be Warranted

By HospiMedica International staff writers
Posted on 28 May 2014
Among patients with a specific type of colorectal cancer with limited metastasis to the liver, imaging using positron emission tomography (PET) and computed tomography (CT) before surgery did not significantly change the surgical treatment of the cancer, compared with just using CT scanning. More...


The findings were published May 13, 2014, in the Journal of the American Medical Association (JAMA). Colorectal cancer is a leading cause of cancer death. About 50% of patients present with or subsequently develop cancer that has spread to the liver. Some patients with liver metastases are candidates for surgery to have the cancer removed. However, unidentified occult metastases at the time of surgery can render the operation noncurative. Therefore, long-term survival after surgical resection (removal) for colorectal cancer liver metastases is only approximately 50%. PET-CT imaging technology could help avoid noncurative surgery by identifying patients with occult metastases, according to the researchers.

Carol-Anne Moulton, MB, BS, from the University Health Network (Toronto, Canada), and colleagues randomly ascribed patients with colorectal cancer treated by surgery with resectable metastases based on CT scans to PET-CT (n = 270) or CT only (n = 134) to determine the effect on the surgical treatment of these patients. The study, conducted between 2005 and 2013, involved 21 surgeons at nine hospitals in Ontario.

Of the 263 patients who received PET-CT scans, 111 provided new data: 62 were categorized as negative and 49 had abnormal or suspicious lesions. Change in management (canceled, more extensive liver surgery, or surgery performed on additional organs) as a result of the PET-CT findings occurred in 8.7% of patients; 2.7% avoided noncurative liver surgery. Overall, liver resection was performed on 91% of patients in the PET-CT group and 92% of the control group.

The median follow-up was three years. The researchers discovered no substantial disparity in survival or disease-free survival between patients in the PET-CT group vs. the control group. “Many countries struggle to maintain quality healthcare within existing budgets. This is difficult because of increasing healthcare costs as a result of an aging population and the expense of new therapies and technologies, including diagnostic and functional imaging,” the authors wrote in their article. “Among patients with potentially resectable hepatic metastases of colorectal adenocarcinoma, the use of PET-CT compared with CT alone did not result in frequent change in surgical management. These findings raise questions about the value of PET-CT scans in this setting.”

Related Links:

University Health Network



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Resorbable Bovine Collagen Membrane
GenDerm
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: Shutterstock

AI-Derived Heart Age Linked to Cardiovascular and Dementia-Related Mortality

Cardiovascular disease is increasingly associated with dementia-related mortality and other forms of age-related decline. Identifying people with greater long-term vulnerability before severe outcomes... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.